VIR
Vir Biotechnology, Inc.
Key Financials
Operating Income
$-479328000
↑ 18.4%
Net Income
$-437987000
↑ 16.1%
Revenue
$68.6M
↓ 7.6%
Total Assets
$1.0B
↓ 28.3%
EPS (Diluted)
$-3.16
↑ 17.5%
Cash & Equivalents
$232.2M
↑ 4.1%
Total Liabilities
$237.5M
↓ 4.4%
Shareholders' Equity
$2.1B
↑ 45.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 4 | 4/30/2026 | View on SEC |
| 144 | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| ARS | 4/16/2026 | View on SEC |
| DEFA14A | 4/16/2026 | View on SEC |
| DEF 14A | 4/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VIR |
| Company Name | Vir Biotechnology, Inc. |
| CIK | 1706431 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 415-906-4324 |